Target intelligence / Profile preview

Oxalic acid (in gastrointestinal tract lumen)

Molecular classification
Other (small molecule/metabolite)
01

Overview

Oxalic acid is a small, strong dicarboxylic acid found in high levels in certain vegetables and plant foods, present in the gastrointestinal tract both from dietary sources and endogenous secretion[1][7][8][9]. In the intestine, free oxalic acid can bind to minerals such as calcium and magnesium, reducing their absorption[1][7][9]. Some oxalic acid is degraded by oxalate-metabolizing bacteria (notably Oxalobacter formigenes), but the remainder may be absorbed into the body and ultimately excreted via urine, contributing to the risk of calcium oxalate kidney stone formation in susceptible individuals[2][8][9][10]. Unlike classical drug targets such as enzymes or receptors, free oxalic acid is a metabolite and not a macromolecular target; thus, it is not considered a therapeutic target itself. In summary, "Gastrointestinal tract luminal free oxalic acid" is not a canonical target but instead reflects a small molecule/metabolite with physiological and clinical consequences relevant to nutrition, nephrology, and gastrointestinal health.

Other names
Oxalate (when deprotonated)free oxalategastrointestinal oxalic acidGI lumen oxalic acid
02

Mechanism of action

Not applicable (since this is not a molecular target for drugs); however, some probiotics or therapeutics (e.g., certain bacteria like Oxalobacter formigenes) can degrade oxalate in the gut[5][7][9]

03

Biological functions

Binds minerals (e.g., calcium, magnesium) in the gut, impairing absorption[1][6][7][9]Contributes to urinary oxalate excretion or kidney stone formation after absorption[2][8][10]
04

Disease associations

Kidney stone formation (calcium oxalate nephrolithiasis)[2][8][10]Hyperoxaluria (primary and secondary)[2][10]Reduced mineral/nutrient absorption[1][6][7][9]
05

Safety considerations

High dietary intake of oxalate can increase risk of kidney stones and reduce absorption of essential minerals, potentially leading to deficiencies[1][6][9]GI irritation at high levels[6]
06

Biomarkers

Urinary oxalate (as indicator of oxalate absorption or stone risk)[8]

Beyond the preview

Go deeper on Oxalic acid (in gastrointestinal tract lumen).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oxalic acid (in gastrointestinal tract lumen).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call